Jung Un Shin

Associate | She/Her/Hers

Overview

Jung is an associate in Crowell & Moring’s Patents Group. Her practice focuses on securing robust patents for clients across diverse technologies and offering strategic intellectual property guidance. Jung's experience encompasses counseling clients on patent infringement and invalidity investigations, licensing, and trade secret matters. 

Through her externship for Chief Justice Annette Kingsland Ziegler at the Wisconsin Supreme Court, she gained valuable insights into litigation practices and procedures.

Before starting her legal career in the U.S., Jung worked at law firms in Seoul as a Korean patent attorney, acquiring extensive experience in patent prosecution and litigation in the chemical and pharmaceutical fields.

Career & Education

    • University of Wisconsin Law School, J.D., 2024
    • Korea Advanced Institute of Science and Technology, Master’s Degree, Intellectual Property, 2016
    • Hanyang University, B.S., cum laude, Chemistry, 2010
    • University of Wisconsin Law School, J.D., 2024
    • Korea Advanced Institute of Science and Technology, Master’s Degree, Intellectual Property, 2016
    • Hanyang University, B.S., cum laude, Chemistry, 2010
    • Illinois
    • U.S. Patent and Trademark Office (USPTO)
    • Korean Patent Attorney
    • Illinois
    • U.S. Patent and Trademark Office (USPTO)
    • Korean Patent Attorney
    • Korean Patent Attorneys Association
    • Illinois Bar Association
    • Korean Patent Attorneys Association
    • Illinois Bar Association
    • Korean
    • Korean

Jung's Insights

Client Alert | 3 min read | 07.21.25

Bypass Applications in U.S. Patent Practice: A Strategic Alternative to National Stage Entry

Applicants entering the U.S. national phase of an international (PCT) application have two options: enter the national stage under 35 U.S.C. §371 or file a “bypass” national application under 35 U.S.C. § 111(a). A bypass application allows applicants to file a new U.S. application that claims priority to the PCT application, treating the PCT application as a U.S. parent and bypassing the traditional national phase entry. Depending on the applicant’s goals and strategy, bypass applications can be filed as a continuation, divisional, or continuation-in-part (CIP)....

Jung's Insights

Client Alert | 3 min read | 07.21.25

Bypass Applications in U.S. Patent Practice: A Strategic Alternative to National Stage Entry

Applicants entering the U.S. national phase of an international (PCT) application have two options: enter the national stage under 35 U.S.C. §371 or file a “bypass” national application under 35 U.S.C. § 111(a). A bypass application allows applicants to file a new U.S. application that claims priority to the PCT application, treating the PCT application as a U.S. parent and bypassing the traditional national phase entry. Depending on the applicant’s goals and strategy, bypass applications can be filed as a continuation, divisional, or continuation-in-part (CIP)....